Patent ID: 6476033
Filing Date: 2002-11-05
Classification: A61K,A61P

Abstract:
A solid pharmaceutical form comprising modification D of doxazosin mesylate, wherein the modification D of doxazosin mesylate is characterized by lines in an X-ray diffractogram at the following values of 2 theta: 5.72Â±0.2Â°; 11.10Â±0.2Â°; 11.46Â±0.2Â°; 14.14Â±0.2Â°; 17.01Â±0.2Â°; 17.78Â±0.2Â°; 18.33Â±0.2Â°; 20.73Â±0.2Â°; 21.70Â±0.2Â°; 23.12Â±0.2Â°; 24.28Â±0.2Â°; 26.58Â±0.2Â°.